A citation-based method for searching scientific literature

Josep Tabernero, Paulo M Hoff, Lin Shen, Atsushi Ohtsu, Manish A Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng-Wong, Katherine Kim, Yoon-Koo Kang. Lancet Oncol 2018
Times Cited: 195



Atsushi Ohtsu, Manish A Shah, Eric Van Cutsem, Sun Young Rha, Akira Sawaki, Sook Ryun Park, Ho Yeong Lim, Yasuhide Yamada, Jian Wu, Bernd Langer, Michal Starnawski, Yoon-Koo Kang. J Clin Oncol 2011
Times Cited: 806




List of shared articles



Times cited

Efficacy and safety of targeted drugs in advanced or metastatic gastric and gastroesophageal junction cancer: A network meta-analysis.
Hongxia Gong, Yun Su, Lixia Zhao, Li Ma, Liying Zhang, Liangying Hou, Tingting Li, Shiwei Niu, Han Zhang, Chenghao Li,[...]. J Clin Pharm Ther 2022
0

Systemic therapy for gastric cancer: Perioperative strategies and beyond.
Christopher Cann, Kristen K Ciombor. J Surg Oncol 2022
0

The dawn of precision medicine in diffuse-type gastric cancer.
Akira Ooki, Kensei Yamaguchi. Ther Adv Med Oncol 2022
2

Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types.
Aracelis Z Torres, Nathan C Nussbaum, Christina M Parrinello, Ariel B Bourla, Bryan E Bowser, Samuel Wagner, David C Tabano, Daniel George, Rebecca A Miksad. Adv Ther 2022
0

Molecular pathogenesis and emerging targets of gastric adenocarcinoma.
Abby Ivey, Hillary Pratt, Brian A Boone. J Surg Oncol 2022
2


The changing face of gastric cancer: epidemiologic trends and advances in novel therapies.
Raghav Chandra, Neeraja Balachandar, Sam Wang, Scott Reznik, Herbert Zeh, Matthew Porembka. Cancer Gene Ther 2021
12

Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting.
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, Heejung Chae, Eo Jin Kim, Mee-Sun Moon, Yoon-Koo Kang. Cancer Res Treat 2021
2

Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease.
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, Leah M Chase, Bryan F Peterson, Natalie Reizine, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart,[...]. Cancer Discov 2021
22

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Felipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Virginia Arrazubi, Raquel Hernandez, Juana M Cano, Ana Custodio, Carles Pericay Pijaume, Gema Aguado, Nieves Martínez Lago,[...]. Gastric Cancer 2021
1

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.
Yoshiaki Nakamura, Akihito Kawazoe, Florian Lordick, Yelena Y Janjigian, Kohei Shitara. Nat Rev Clin Oncol 2021
27

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, Davide Bosso, Laura Attademo, Cinzia Cardalesi, Anna Diana, Antonietta Fabbrocini, Teresa Fabozzi, Pasqualina Giordano,[...]. J Clin Med 2021
4

Hopes and failures in front-line advanced HER2-positive gastric cancer therapy.
Fanming Kong, Yang Yao, Renfen Deng, Xiaojiang Li, Yingjie Jia. Anticancer Drugs 2021
0

Targeted and immunotherapy in the era of personalised gastric cancer treatment.
Silvia Catanese, Florian Lordick. Best Pract Res Clin Gastroenterol 2021
7

Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
Daniel V Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J Klempner, Zev A Wainberg, Manish A Shah, Sun Young Rha, Atsushi Ohtsu, Astra M Liepa,[...]. Oncologist 2021
2